[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620666":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":27,"responsibleParty":49,"collaborators":19,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":19,"enrollmentInfo":63,"targetDuration":19,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":30,"whyStopped":19,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Université de Sherbrooke","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Thyroid Artery Embolization","EXPERIMENTAL","Patients with diagnosis of Goiter with compressive symptoms in which other alternatives lack or are refused by the patient himself.",[13],"Procedure: Thyroid Artery Embolization",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","Interruption of blood flow that supplies thyroid nodule using embolization technique.",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Laurent Fradet, MD FRCSC","CONTACT","+1-819-346-1110","14901","Laurent.Fradet@USherbrooke.ca",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Centre Hospitalier Universitaire de Sherbrooke","RECRUITING","Sherbrooke","Quebec","J1H5H3","Canada","CA",{"type":37,"coordinates":38},"Point",[39,40],-71.89908,45.40008,{"lat":40,"lon":39},[43,45],{"name":22,"role":23,"phone":44,"phoneExt":25,"email":26},"1-819-346-1110",{"name":46,"role":23,"phone":44,"phoneExt":47,"email":48},"Jaime Alberto Reina, BSc","26953","jaime.alberto.reina.marino@usherbrooke.ca",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Laurent Fradet","MD, FRCSC","100620666","thyroid-artery-embolization-for-the-treatment-of-compressive-goiters-100620666",false,"NCT07360587","Thyroid Artery Embolization for the Treatment of Compressive Goiters.","Thyroid Artery Embolization for the Treatment of Compressive Goiters: a Prospective Cohort Study.","TAE","Inclusion Criteria:\n\n* Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND\n* Ineligible for surgery\u002Fablative treatments or preference for TAE over other treatments AND\n* TiRADS category 1, 2, 3 or 4 AND\n* Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND\n* Patient at least 18 years old.\n\nExclusion Criteria:\n\n* Comorbidities precluding endovascular procedure OR\n* TiRADS category 5 OR\n* Bethesda categories IV, V, VI on biopsy OR\n* Refusal of the patient to participate OR\n* Uncontrolled severe hyperthyroidism OR\n* Minor patient.","ALL","18 Years",{"count":64,"type":65},20,"ESTIMATED","INTERVENTIONAL",[68],"NA","Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.",[71],"Thyroid Nodules",[73,9,74],"Goiter","thyroid nodule","2026-01-16",{"date":77,"type":78},"2026-01-22","ACTUAL",{"date":80,"type":65},"2026-01-31",{"date":82,"type":65},"2029-12-31",{"name":5,"class":6},1]